Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says
This article is from
The Cancer Letter
archive.
Vol. 37 No. 11 | November 28, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Proteomics Used To Find Predictor Of Response In FAP
April 30, 2004
TCL Archive
NCI Budget for FY 1977 Would Halt New Research
January 23, 1976
TCL Archive
Tucson Conference Could Be Lively
February 16, 1979
TCL Archive
Breast Cancer Treatment Studies Need Standard Definitions – Carbone
May 10, 1974
TCL Archive
Kansas City Clinic Settles Medicare Overbilling Claim
June 6, 2014
TCL Archive
NCI Offers 200 Cell Lines to Scientist
May 6, 1983